Trademark: 79115519
Word
NUMARES
Status
Registered
Status Code
739
Status Date
Thursday, March 5, 2020
Serial Number
79115519
Registration Number
4464382
Registration Date
Tuesday, January 14, 2014
Mark Type
4
Filing Date
Wednesday, January 4, 2012
Published for Opposition
Tuesday, October 29, 2013

Trademark Owner History
numares AG - Original Registrant
Numares GmbH - Owner At Publication

Classifications
9 Scientific apparatus and instruments, namely, pipettors, automatic pipetting systems, namely, robotics for moving a sample, robotics for moving NMR, namely, nuclear magnetic resonance, tubes, means for housing containers containing reagents, control substances or calibrating substances, and a pipettor for analyses in laboratories of human body fluids or their metabolites, of plant extracts, namely, of liquid aqueous or organic plant extracts, and of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, centrifuges, namely, laboratory apparatus, glass tubes for scientific purposes and nuclear magnetic instruments; measuring apparatus and instruments, namely, nuclear magnetic instruments; testing apparatus not for medical purposes, namely, nuclear magnetic instruments; food analysis apparatus, namely, nuclear magnetic instruments; diagnosis apparatus, not for medical purposes, namely, nuclear magnetic instruments; spectroscopes; recorded computer software, namely, analytical software used to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, and software for controlling spectroscopes and nuclear magnetic instruments; downloadable computer programs featuring analytical software for use in obtaining results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, and software for controlling spectroscopes and nuclear magnetic instruments
5 Pharmaceutical preparations and veterinary preparations, namely, contrast agents and agents for monitoring metabolic processes, for diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, or for monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; chemical reagents for medical or veterinary purposes, namely, contrast agents and agents for monitoring metabolic processes, for diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, or for monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; chemical reagents for medical or veterinary purposes; chemicals in the nature of diagnostic preparations for medical or veterinary analyses in laboratories; chemico-pharmaceutical preparations, namely, contrast agents and agents for monitoring metabolic processes, for diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, or for monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; chemical preparations for pharmaceutical, medical and veterinary use, namely, for monitoring metabolic processes, for diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, or for monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; biological preparations for medical or veterinary purposes, namely, for monitoring metabolic processes, for diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, or for monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; diagnostic preparations for medical and veterinary use; assortments, namely, kits, comprising, chemicals in the nature of preparations for monitoring metabolic processes, for diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, or for monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes for medical and veterinary purposes, NMR, namely, nuclear magnetic resonance, tubes, and a rack for housing said NMR tubes
45 Licensing of computer software in the nature of legal services; licensing of intellectual property rights, namely, industrial property rights and copyrights; licensing of research methods
1 Chemicals for use in industry and science; chemical preparations, namely, control solutions, diluents, calibrating substances, reference substances, and concentration markers for analyses in laboratories of human body fluids or their metabolites, of plant extracts, namely, of liquid aqueous or organic plant extracts, and of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, other than for medical or veterinary purposes; chemical reagents other than for medical or veterinary purposes; biological preparations for use in analytic processes, namely, in NMR, namely, nuclear magnetic resonance, analyses, and for use in the identification and quantification of ingredients of chemical or biological compositions, other than for medical or veterinary use; diagnostic preparations, other than for medical or veterinary purposes; assortments, namely, kits, comprising, control solutions and calibrating substances for use in industry and science, for analyses in laboratories of human body fluids or their metabolites, of plant extracts, namely, of liquid aqueous or organic plant extracts, and of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, and for the identification and quantification of ingredients of chemical or biological compositions other than for medical or veterinary purposes, NMR, namely, nuclear magnetic resonance, tubes, and a rack for housing said NMR tubes
42 Scientific and technological services and related research and design services, namely, scientific research and development and product research and development in the fields of spectroscopy, of analyses of human body fluids or their metabolites, of analyses of plant extracts, namely, of liquid aqueous or organic plant extracts, of analyses of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; industrial analysis and research services in the fields of spectroscopy, of analyses of human body fluids or their metabolites, of analyses of plant extracts, namely, of liquid aqueous or organic plant extracts, of analyses of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; computer hardware and software design and development; biological research; computer programming; installation and maintenance of computer software; updating of computer software; rental of computer software; scientific experiments in the fields of spectroscopy, of analyses of human body fluids or their metabolites, of analyses of plant extracts, namely, of liquid aqueous or organic plant extracts, of analyses of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; measurement services, namely, performing and evaluating measurements in the fields of spectroscopy, of analyses of human body fluids or their metabolites, of analyses of plant extracts, namely, of liquid aqueous or organic plant extracts, of analyses of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; development and research services, namely, analysis services in the nature of scientific analyses in the fields of molecular biology, biochemistry and spectroscopy; development of research methods, namely, of scientific methods in the fields of spectroscopy, of analyses of human body fluids or their metabolites, of analyses of plant extracts, namely, of liquid aqueous or organic plant extracts, of analyses of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; development and research services in the fields of molecular biology, biochemistry and spectroscopy; scientific research in the fields of molecular biology, biochemistry and spectroscopy; services of medical and bacteriological research laboratories, namely, medical research and bacteriological research; services of chemical laboratories, namely, medical research and bacteriological research; services of chemical laboratories in the fields of spectroscopy, of analyses of human body fluids or their metabolites, of analyses of plant extracts, namely, of liquid aqueous or organic plant extracts, of analyses of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes
Color is not claimed as a feature of the mark.
The word(s) "NUMARES" has no meaning in a foreign language.

Trademark Events
Aug 9, 2012
Sn Assigned For Sect 66a Appl From Ib
Dec 13, 2012
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 10, 2012
New Application Office Supplied Data Entered
Aug 10, 2012
Assigned To Examiner
Aug 14, 2012
Application Filing Receipt Mailed
Aug 21, 2012
Non-Final Action Written
Aug 22, 2012
Non-Final Action (Ib Refusal) Prepared For Review
Aug 22, 2012
Refusal Processed By Mpu
Aug 22, 2012
Non-Final Action Mailed - Refusal Sent To Ib
Sep 9, 2012
Refusal Processed By Ib
Dec 13, 2012
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 1, 2013
Change Of Name/Address Rec'd From Ib
Aug 22, 2013
Correspondence Received In Law Office
Jan 29, 2013
Teas Response To Office Action Received
Jan 31, 2013
Assigned To Lie
Feb 6, 2013
Correspondence Received In Law Office
Feb 6, 2013
Teas/Email Correspondence Entered
Feb 27, 2013
Non-Final Action Written
Feb 27, 2013
Non-Final Action E-Mailed
Feb 27, 2013
Notification Of Non-Final Action E-Mailed
Aug 22, 2013
Teas Response To Office Action Received
Aug 22, 2013
Teas/Email Correspondence Entered
Sep 19, 2013
Examiner's Amendment Entered
Sep 19, 2013
Examiners Amendment -Written
Sep 19, 2013
Examiners Amendment E-Mailed
Sep 19, 2013
Notification Of Examiners Amendment E-Mailed
Oct 9, 2013
Notification Of Possible Opposition Sent To Ib
Sep 19, 2013
Approved For Pub - Principal Register
Sep 23, 2013
Law Office Publication Review Completed
Oct 9, 2013
Notification Of Notice Of Publication E-Mailed
Oct 9, 2013
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 29, 2013
Official Gazette Publication Confirmation E-Mailed
Jan 14, 2019
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Oct 27, 2013
Notification Processed By Ib
Oct 29, 2013
Published For Opposition
Jan 14, 2014
Registered-Principal Register
Apr 14, 2014
Final Disposition Notice Created, To Be Sent To Ib
May 28, 2014
Final Disposition Processed
May 28, 2014
Final Disposition Notice Sent To Ib
Jun 13, 2014
Final Decision Transaction Processed By Ib
Nov 19, 2015
Change Of Name/Address Rec'd From Ib
Jan 14, 2020
Teas Section 71 & 15 Received
Nov 12, 2022
New Representative At Ib Received
Mar 5, 2020
Case Assigned To Post Registration Paralegal
Mar 5, 2020
Registered - Sec. 71 Accepted & Sec. 15 Ack.
Mar 5, 2020
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Jan 28, 2022
Change Of Name/Address Rec'd From Ib
Feb 24, 2022
International Registration Renewed
Jun 21, 2024
Teas Section 71 Received
Jan 14, 2023
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Dec 31, 2022
New Representative At Ib Received

Trademark Alertz updated from USPTO on 2030-01-24